Health & Research Goals
Beyond Health LabIsolated Peptide
Hexarelin
Classification
Research Peptide
USA
COA
$$Cost
Vial Size
2 mg
Available in:2mg
Frequency
—
Cycle
—
Storage
—
Half-Life~55-70 minutes
Onset2-4 weeks
RouteSubcutaneous injection
EvidenceModerate (clinical studies)
MonitoringIGF-1, cortisol, prolactin
Primary Description
Key Benefits
- Strong GH release
- Cardioprotective
- Muscle growth
Proposed Mechanisms of Action
Proposed mechanisms based on available research
Research Evidence & Clinical Data
Review of available research evidence and clinical data
Scientific References
- 1.Growth hormone-releasing activity of hexarelin in humans. A dose-response studyEur J Clin Pharmacol1994
- 2.
- 3.The cardiovascular action of hexarelinJ Geriatr Cardiol2014
Safety Profile
Common Side Effects
- Increased hunger
- Cortisol elevation
- Prolactin increase
Contraindications
- Active cancer
- Cardiac conditions
Research Protocols
Dosing protocols based on available research data
Dosing Protocols
Monitoring & Risk Management
Monitoring guidelines based on available data
No Specific Monitoring Protocol
No structured monitoring data is available for this compound. Always consult a healthcare professional before use.